Avances en biotecnoloía reproductiva en bovinos: de la inseminación artificial a la clonación by Bertolini, Maecelo & Bertolini, L.R
184
Rev. Med. vet. Zoot. 2009. 56:184-194 Revisión
AdVAnCeS in RePRodUCtiVe teCHnoLoGieS in CAttLe: 
FRoM ARtiFiCiAL inSeMinAtion to CLoninG 
Bertolini M1 and Bertolini Lr
Center of agroveterinarian sciences (Cav)
santa Catarina state University (UdesC), Brazil
ABSTRACT
The urge for the control of reproductive processes in animals has propelled a great gain in 
knowledge, also setting off the development of four generations of assisted reproductive 
technologies (arT) for humans and animals. The use of assisted reproductive techniques 
has been of great importance in livestock production. In general terms, the main first three 
generations of ARTs, including 1) artificial insemination (AI) and gamete and embryo 
freezing, 2) multiple ovulation and embryo transfer (MOeT) and 3) in vitro fertilization 
(ivF) procedures, have matured into successful commercial applications, facilitating the 
increase in production through genetics, the reduction in generation intervals, the control of 
diseases, and the cutback in production costs. The fourth generation of arT encompasses 
processes that are still more experimental, comprising cloning by nuclear transfer (nT) of 
embryonic or somatic cells, transgenesis, and stem cell biology. such technologies are in-
tertwined with one another and with currently available molecular tools, being completely 
dependent upon the previous generations of technologies. However, many reproductive 
challenges still hinder maximal livestock reproductive performance, affecting productivity 
and profitability. It is clear that the application of such technologies as lucrative activities 
will remain questionable if not associated with other components of animal production, 
such as animal health, nutrition and adequate animal husbandry practices.
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AvANCES EN BIOTECNOLOGíA REPRODuCTIvA EN 
BOvINOS: DE LA INSEMINACIÓN ARTIFICIAL A LA 
CLonACión
ReSUMen
el afán por controlar los procesos reproductivos en animales ha llevado a una gran ganancia 
en conocimiento, impulsando el desarrollo de cuatro tecnologías reproductivas asistidas 
(arTs) para animales y humanos. el uso de arTs ha sido de gran importancia en la produc-
ción ganadera. en términos generales, las tres principales generaciones de arT, incluyendo 
1) inseminación artificial (AI) y congelación de gametos y embriones, 2) superovulación 
y transferencia de embriones (MOeT) y 3) procedimientos de fertilización in Vitro, han 
madurado en aplicaciones comerciales exitosas, facilitando el incremento en la producción 
a través de la genética, reducción del intervalo generacional, control de enfermedades, y 
reducción de costos de producción. La cuarta generación de arTs incluye procesos que aún 
son muy experimentales, como transferencia de núcleos (nT) de células somáticas, trans-
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mal management, disease control, nutrition, 
and reproduction. Therefore, the benefits of 
arT and genetic improvement can only be 
expressed if other aspects of livestock man-
agement are improved, including the produc-
ers’ education, in which any implementation 
of reproductive biotechnology and genetics 
should be part of a broader program to im-
prove health and nutrition.
The most consolidated reproductive tech-
niques that have been genetically relevant in 
the past half a century take part of the first 
three ART generations, including artificial 
insemination, cryopreservation of gametes 
or embryos, induction of multiple ovulations, 
ultrasonography, embryo transfer and in vi-
tro fertilization. Third and fourth generation 
technologies such as sexed semen or embry-
os, cloning, transgenesis, stem cell biology 
and molecular diagnosis have the potential 
to enhance the influence of superior animals 
on production, but their commercial applica-
tions have been limited. Furthermore, the use 
of genomics, proteomics, metabolomics and 
bioinformatics in the study of reproduction 
will allow a greater understanding of the lim-
itations to efficient reproductive processes. 





Artificial Insemination (AI). Artifi-
cial insemination is the first generation of 
intRodUCtion 
The biological and technological advanc-
es observed during the past six decades have 
spawned the development of four generations 
of assisted reproductive technologies (arT). 
Historically, aside from the mere scientific 
curiosity, the emergence and development of 
reproductive technologies have been driven 
by the economical gain offered by the poten-
tial increase in the number of offspring from 
genetically superior animals or simply to 
safeguard the genetic pool of infertile or sub-
fertile animals. in other words, reproductive 
technologies were developed to offer possi-
bilities for wider use of superior germplasm 
(1). For one to take full advantage of the ben-
efits of assisted reproductive technologies 
there is a need for the support of long-term 
and basic research for the understanding of 
the complex mechanisms that underlie the 
physiology of the female and male reproduc-
tive systems and their reproductive cycles. 
As novel findings emerge, new perspectives 
and applications are proposed, tested, re-
fined and, finally, put in practice. However, 
it is not possible, for example, to separate 
reproductive and genetic biotechnologies for 
a successful genetic manipulation program. 
Consequently, application of biotechnologies 
to livestock usually falls within four catego-
ries: a) management or husbandry, b) herd 
health, c) nutrition and growth, and (d) re-
production and genetics. in this view, genetic 
improvement is seldom introduced without 
other improvements in aspects such as ani-
génesis, y biología de células madre. estas tecnologías se intercalan las unas con las otras y 
con las herramientas moleculares actuales, dependen completamente de las generaciones de 
tecnologías previas. sin embargo, hay muchos retos reproductivos que no permiten alcanzar 
el potencial reproductivo máximo, afectando la productividad y la rentabilidad. es claro 
que la aplicación de tales tecnologías como actividades lucrativas se mantendrán cuestiona-
das si no se asocian a otros componentes de la producción pecuaria, como la salud animal, 
nutrición, y prácticas de manejo adecuadas.
Palabras clave: Biotecnología de la reproducción, inseminación artificial, transferencia de 
embriones, clonación, ivF
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Cryopreservation of gametes and 
Embryos. it was the attainment of suc-
cessful protocols for semen cryopreserva-
tion that made ai thrive as an accessible 
reproductive technology that allowed the 
widespread use of genetically superior sires 
(3). Frozen semen boosted the dairy indus-
try, for making ai simpler, economical, 
and successful, with more than 60 percent 
of dairy cows in the Usa bred by ai. Con-
versely, due to the typical extensive produc-
tion system, ai accounts for less than 5 
percent of inseminations in beef cattle. 
similar to ai, embryo cryopreservation 
allowed the global commercialization of 
animals of high genetic merit, as embryos. 
embryo freezing has been a successful 
procedure in cattle for almost three decades 
and it became of routine use in the field. 
However, in vitro-produced (ivP) bovine 
embryos are more sensitive to cryopreser-
vation than their in vivo-derived counter-
parts (4). Many efforts have been focused on 
the adjustment of cryopreservation methods 
to special requirements of ivP embryos, 
with vitrification procedures appearing as 
a promising approach for the cryopreserva-
tion of ivP bovine embryos than any other 
freezing methods (5, 6). The open-pulled 
straw (OPs) technology has been proven 
successful not only for the vitrification of 
bovine oocytes and ivP embryos but also to 
be combined with the in-straw warming and 
cryoprotectant dilution method for direct 




Multiple Ovulation and embryo Trans-
fer (MOeT). embryo transfer (eT), initiated 
about four decades ago, is a more advanced 
reproductive biotechnology that also takes 
advantage of ai procedures, being consid-
arT, which has been in use for more than 
200 years. as a modern technology, ai 
with fresh or frozen semen has been the 
most successful and efficient reproductive 
technology in animal production for the 
last six decades. The use of ai had a major 
impact on genetic improvement programs 
in developed countries, associated with 
1,0 to 1,5% annual rates of genetic gains 
in dairy cattle (2). Through the prospec-
tive genetic gain attained by using ai, it 
is estimated that approximately 50% of 
the increase in milk production efficiency 
observed in developed countries during the 
second half of the 20th century can be at-
tributed only to the genetic gain obtained by 
the widespread use of ai over conventional 
breeding, with the other 50% corresponds 
to significant advancements in the produc-
tion systems per se, including herd health, 
general management, and nutrition (3). The 
use of ai has boosted the development of 
efficient programs involving synchroniza-
tion of estrus or even ovulation, without 
requiring heat detection. With the advent 
of commercially available prostaglandin 
F2α and its analogues in the 1970s, estrous 
synchronization systems were developed to 
assist producers to incorporate ai into their 
operations by reducing time and labor asso-
ciated with estrus detection. recently, with 
better understanding of endocrine profiles 
of females throughout the estrous cycle, 
economical and efficient systems have been 
developed for the synchronization of ovula-
tion, which allows producers to ai animals 
at a predetermined fixed-time, eliminating 
estrus detection. These fixed-time AI sys-
tems work well for the synchronization of 
estrus/ovulation, and also for the induction 
of cyclicity in anestrous animals. in addi-
tion, programs can be scheduled in advance 
for the ai at the most appropriate period, 
under each specific circumstance. 
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ered the second generation of arT. The 
progress achieved during the past 25 years 
has positioned commercial bovine embryo 
transfer as a large international business (7, 
8). Contributing factors that significantly 
added for the increase in worldwide market-
ability of embryos were the development 
of successful cryopreservation and the use 
of washing procedures to obtain specified 
pathogen-free embryos (7). in 2005, approx-
imately 130 thousand bovine females were 
flushed, for more than 600 thousand bovine 
embryos being transferred, representing a 
10% worldwide increase over the previous 
year, with north and south america and 
asia accounting for 45, 21, and 19% of the 
total worldwide activity, respectively (9). 
The combination of multiple ovulation 
and embryo transfer (MOeT) represents 
for the female what the ai has been for the 
male, allowing the production of multiple 
progeny from genetically superior females. 
However, eT and ai can be very useful, 
provided that good production practices 
(husbandry, nutrition, and management) are 
in place. One of the limiting factors associ-
ated with MOeT technology is the variabil-
ity and lack of predictability in follicular 
development response and embryo produc-
tion following a superovulatory treatment 
(7). The real causes for such problems are 
likely to be associated with changes in the 
endocrine profiles of donor females by ex-
ogenous hormone treatments (7). in reality, 
little progress was attained, as the average 
number of transferable embryos per donor 
and the side effects on the reproductive per-
formance of the donors remain unchanged 
in the past two decades (9, 10). as for ai, the 
use of MOeT schemes forced the develop-
ment of estrus or ovulation synchronization 
protocols that have facilitated and shortened 
considerably the whole process. Fixed-time 
eT and direct eT of frozen embryos are 
satellite procedures currently in broad use 
worldwide. However, MOeT programs are 
expensive, mostly due to the cost of labor 
and hormone treatments. For those reasons, 
MOeT will probably continue to be more 
intensively used by elite cattle producers.
Ultrasonography. Ultrasonography is 
among the most important image techniques 
for a wide number of applications in repro-
duction in cattle, with interests ranging 
from scientific to commercial purposes. 
since the mid-1980s, many reports have es-
tablished the accuracy of ultrasonography 
as a tool for the study of reproductive pro-
cesses in cattle (11, 12, 13). This noninva-
sive technology allows the study of the same 
specimens for the course of gestation with-
out compromising the viability of the con-
ceptus. Using ultrasonography, the phenom-
enon of follicular dynamics was discovered 
and well described in cattle, which has al-
lowed a tremendous advance in our ability 
to understand and manipulate the estrous 
cycle and, consequently, fertility. Ultraso-
nography can exceed rectal palpation under 
field conditions for the assessment, charac-
terization and enhancement of the bovine 
reproductive status of both the individual 
animals and the herd as a whole. This meth-
od has been effectively used for the a) as-
sessment of ovarian activity and structures; 
b) diagnosis of pathologies of the genital 
tract in males and females; c) detection of 
abnormal pregnancies; d) determination of 
embryonic and fetal viability; e) identifica-
tion of twins; f) prediction of fetal gender 
and; g) for the early diagnosis of pregnancy 
and embryonic/fetal losses, among other 
uses (13). Ultrasonography is an early and 
accurate diagnostic tool used to improve the 
reproductive efficiency of herds and to en-
hance bovine reproductive management. 
Low conception rates and embryonic mor-
tality are common problem in dairy herds, 
particularly when managed intensively. For 
the optimal re-utilization of such animals, 
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stages of development that allow them to be 
transferred to female recipients. Today, the 
ivP of bovine embryos became routinely 
used for scientific, conservation, and/or 
commercial purposes. The ivP technology 
has shown a remarkable increase in effi-
ciency over the years, both qualitatively and 
quantitatively, which has been manifested 
by ascending pregnancy rates obtained after 
the transfer of embryos to host recipients. 
Many advantages have been identified for 
the use of this technology over conventional 
systems for the production of embryos, with 
cost of production being one of the most 
important. 
Ovum pick up (OPU). The in vivo as-
piration of antral follicles (ovum pick up) 
is a nonsurgical technique adapted from 
the human in late 1980s that uses an ultra-
sound-guided needle to aspirate immature 
oocytes from the ovaries of females of any 
age (14). Once the immature oocytes have 
been removed from the ovary, they are sub-
mitted to ivP procedures. The application 
of OPU/ivP has progressed from treating 
infertile high genetic MOeT cows in com-
mercial situations to enhancing breeding 
scheme designs. also, the use of prepuberal 
females for OPU/ivP may increase the ge-
netic gain in up to 22% (2). Potentially, via 
OPU, a donor european or zebu cow may 
yield 15-20 oocytes each week (collection of 
5-10 twice a week or 15-20 oocytes once a 
week, respectively). Considering the usual 
rates of development and losses obtained 
after ivP and eT, a cow may potentially 
produce 50 to 100 calves each year. not 
surprisingly, a rapid expansion in the com-
mercial application of OPU procedures 
coupled with the ivP technologies was seen 
in the past decade. such phenomenon can be 
clearly seen in Brazil, where approximately 
130,000 ivF-derived embryos, mostly from 
zebu breeds, were reported as transferred 
in 2005, accounting for nearly 50% of all 
the ultrasound scanning can assist with the 
characterization of the reproductive status 
of each individual. in that way, the most ef-
ficient treatment or management decision 
can be made in order to reduce the open in-




The third generation of arT includes 
gamete and embryo sexing, oocyte recovery 
and in vitro fertilization (ivF). additional 
procedures have also evolved, such as gam-
ete intrafallopian transfer (GiFT), zygote 
intrafallopian transfer (ZiFT), and intracy-
toplasmic sperm injection (iCsi), but still 
with limited practical applications. 
In vitro Fertilization (IVF). The in 
vitro production (ivP) technology evolved 
from the interest in developing a system to 
produce embryos completely in the labora-
tory. The achievements attained by this 
technology are truly remarkable if one con-
siders that, in the early days, embryos were 
usually produced using in vivo-matured 
oocytes and, after ivF, zygotes were tran-
siently in vivo-cultured into the oviducts 
of surrogate females (sheep or rabbit) be-
fore the definitive embryo transfer. The 
subsequent development of complete ivP 
systems not only facilitated the process but 
also paved the way to studies that resulted 
in tremendous technological advances and 
novel knowledge in many related areas. The 
in vitro production (ivP) of embryos from 
ivF procedures for bovine embryos con-
sists of three steps: first, in vitro maturation 
(ivM) of primary, germinal vesicle-stage 
oocytes collected directly from the ovaries 
of donor females; second, ivF by combin-
ing in vitro matured oocytes with in vitro 
capacitated sperm cells; and third, in vitro 
culture (ivC) of presumptive zygotes to 
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The fourth generation of assisted repro-
ductive technologies is now on use and en-
tails embryo cloning, transgenesis, stem cell 
biology, also including molecular tools that 
may assist in selection and understanding of 
physiological processes to increase fertility. 
Cloning by Nuclear Transfer (NT). 
The first livestock animal (sheep) was 
cloned in 1986 using cells from early em-
bryos (15). Then, the birth of dolly in July 
1996 by transfer of a somatic-cell nucleus 
of an adult (16) represented the fall of an 
important biological dogma, i.e., that dif-
ferentiated somatic cells could not be re-
programmed to a toti- or pluripotent state 
that would allow development of a new in-
dividual. subsequently, cloning by nT from 
adult somatic cells, or somatic cell nuclear 
transfer (sCnT), was repeated and con-
firmed in an increasing number of animal 
species. Even if still relatively inefficient, 
cloning by sCnT, along with ivF, has also 
contributed to advances and generated great 
interest in many related field
somatic-cell cloning may be accom-
plished for reproductive purposes, i.e., to 
produce a genetically identical copy of the 
individual that supplied the donor cell, or 
for therapeutic purposes, i.e., to produce 
cells or tissue for transplantation back to 
the individual that supplied the donor cell. 
somatic-cell cloning is a rapidly develop-
ing area and a valuable technique to copy 
superior genotypes and to produce or copy 
transgenic animals. The promises behind 
sCnT technology include the possibility 
to duplicate a number of copies of animals 
using somatic cells and the feasibility of 
worldwide ivP activity, and surpassing by 
far the total number of in vivo-derived bo-
vine embryos transferred during that same 
period in that country (9). 
sex determination of sperm and em-
bryos. naturally, the beef industry prefers 
male calves for theirs higher body weights 
and feed efficiency, whereas the dairy in-
dustry prefers heifer calves for milk produc-
tion. Thus, methods to determine the sex of 
sperm or embryos were developed to control 
the sex of the livestock’s offspring. as the 
X-bearing sperm in cattle contains about 
3,8 percent more dna than the Y-bearing 
sperm, sperm cells can be segregated based 
on their DNA content using a specific dye 
that binds to DNA and a flow cytometer/
cell sorter. several companies market sexed 
semen through that process. although the 
process to sort the X and Y bearing sperm 
is slow, with approximately 10 million live 
sperm of each sex obtained per hour, which 
is about the number of live sperm required 
for one dose of frozen semen for ai, this 
procedure determines the sex with higher 
than 95 percent accuracy. nonetheless, the 
use of sexed semen technology is associ-
ated with a reduced number of sperm that 
could be separated in a specified time pe-
riod, lower survival of sorted sperm after 
cryopreservation, and lower fertility (8). 
Therefore, producers contemplating the 
use of sexed semen should understand that 
the product will be more expensive than 
conventional semen and fertility may be 
compromised.
embryo sexing using molecular tools 
attained a significant interest in early 1990s, 
but has lost importance in the past few years. 
Polymerase chain reaction technology is 
currently being used for sexing embryos on 
a small scale. it is likely that this technology 
will be replaced by sexed semen. However, 
its importance will be shifted for its use as 
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yield pluripotent eG cells that display char-
acteristics similar to es cells, but much less 
research has been conducted with PGC cul-
ture and eG cells compared with research 
involving es cells (18).
despite potential uses for es and eG 
cells in biomedical research and application, 
documented isolation of es and eG cells 
having proven in vivo developmental capac-
ity in the homologous species (i.e., chimera 
production) is limited to the laboratory 
mouse, the rabbit and the pig. since the pigs 
share many anatomical and physiological 
features with humans, the isolation of por-
cine es cells from nuclear-transfer cloned 
blastocysts offers an enormous opportunity 
to create an animal model for therapeutic 
cloning and resolve a critical issue in most 
cell and tissue transplants, i.e., graft rejec-
tion by the host. Once created, such animal 
models could be used in clinical trials fol-
lowing therapeutic cloning from wild-type 
stem cells of the same origin. 
Transgenic Animals. a transgenic ani-
mal is defined by having a genetic material 
from another species added to its genome. 
Genetic engineering allows us to bypass 
species restraints altogether to produce ge-
netically modified animals with beneficial 
traits and transmission to future generations 
in a Mendelian fashion (21). Transgenic 
mice, pigs, goats, sheep and cattle were pro-
duced by the pronuclear microinjection of 
a foreign gene. Nevertheless, the efficiency 
of such procedures is still very low, i.e., in 
general, less than 5% carries the transgene 
(22). alternatively, cloning by sCnT offers 
the possibility of genetic manipulations of 
somatic cells in culture prior to cloning, ren-
dering offspring that are transgene carriers. 
This technology has been proven effective 
for the production of transgenic animals by 
random integration of the foreign dna into 
cells (23, 24). With further modifications, 
gene insertions and deletions are possible 
cloning a valuable animal. However, the ef-
ficiency of the cloning technology remains 
low. along with ivF procedures, sCnT 
is associated with increased rates of preg-
nancy losses, placental and fetal alterations, 
dystocia and birth of large calves with lower 
postnatal survival. a relatively low number 
of cloned embryos survive to term (1 to 5%), 
with approximately a third of cloned calves 
not surviving to weaning, and more than 8% 
dying before reaching 4 years of age (17). 
Clearly, more research is needed for the 
understanding of the process involving the 
failures in pre- and postnatal development. 
in the Usa, the Food and drug ad-
ministration (Fda) recently considered 
milk and meat from cloned animals safe 
for human consumption, which will boost 
the use of such reproductive technology in 
that country. Most likely, other countries 
will follow, causing the same phenomenon. 
despite that, many breed associations may 
not approve the registration of cloned cattle.
stem Cell biology: Embryonic stem 
(Es) cells and Embryonic germ (Eg) 
cells. embryonic stem cells are charac-
terized by their self-renewal capacity for 
indefinite proliferation in vitro in an undif-
ferentiated, pluripotent state. embryonic 
stem cells possess the in vitro and in vivo 
capacity to differentiate into any special-
ized cell type, from in vitro formation of 
embryoid bodies to in vivo differentiation 
into somatic and germ cell lineages (18). 
Since the first isolation of mouse ES cells 
(19, 20), they have been extensively used 
both as a model for the study of cell lineage 
and regulation of gene expression during 
mammalian embryogenesis and as a vehicle 
for genetic engineering, functional genom-
ics, and cell-therapy studies. Primordial 
germ cells are embryonic cells that migrate 
from extra-embryonic origins to the sexu-
ally undifferentiated gonad and ultimately 
give rise to gametes. Culture of PGC can 
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Mas (26). a substantial number of genetic 
markers are available to study the genetic 
structure of traits and its use in Mas. By 
genotyping, accurate detection of specific 
dna variations that have been associated 
with measurable effects on complex traits 
can be made. By this way, combining phe-
notypes with genetic markers seems to be 
a promising approach for improving health 
and welfare traits in farm animals. These 
traits are often difficult to define since they 
bear low heritabilities and a corresponding 
lack of genetic gain in conventional selec-
tion and breeding programs (27). several 
QTLs have been identified for farm animals 
and Mas is currently been used in com-
mercial livestock breeding. as an example, 
markers associated with marbling and 
tenderness in cattle are currently available 
in the market. it is anticipated that Mas 
schemes will eventually be more widely 
implemented (14).
ConCLUSionS And FinAL 
ConSideRAtionS 
The control of reproductive processes 
in animals offers numerous advantages, 
serving as an essential instrument for the 
application of biotechnology to livestock 
production. The use of farm animals and 
their products have significantly contrib-
uted to the quality of human health and for 
the establishment of civilization. it is within 
this scope that the first three generations 
of arT have contributed tremendously to 
the satisfaction of the increasing demands 
of the modern society (28). Many produc-
ers are now familiar with more advanced 
methods to enhance reproductive efficiency, 
which may further add potential economic 
efficiency to cattle operations. Artificial 
insemination, estrous synchronization, em-
bryo transfer, in vitro fertilization, sexed-
semen, and cloning are all procedures that 
have already influenced or will further in-
through gene targeting, albeit still techni-
cally challenging and rather inefficient.
at present, no transgenic animal was 
incorporated into breeding programs. 
However, the use of transgenic animals to 
produce therapeutic proteins in the milk has 
been heavily invested and the shortage of 
human cells, tissues and organs and thera-
peutic proteins has increased the pressure 
for the creation of transgenic herds. an-
other application for genetically modified 
animals has been directed at engineering 
animals to render their organs immunologi-
cally compatible for human transplantation 
(xenotransplantation), with the pig being 
currently the species of choice for this re-
search (25). 
The fact that the generation of trans-
genic livestock is expensive and inefficient, 
joined by the reality that most agriculturally 
relevant traits are complex and controlled by 
more than one gene, has limited the use and 
application of transgenic technology. The 
sequencing of the bovine genome, in con-
junction with new methods for modifying 
the genome, is encouraging a resurgence of 
research using transgenic livestock.
Marker-assisted selection (MAS). su-
perior phenotypes have been the focus for 
selective breeding in livestock improvement 
for centuries, which has proven to be very 
successful. However, in recent years, infor-
mation on the organization and functioning 
of genomes of livestock are becoming avail-
able, which can be used in breeding pro-
grams to improve certain traits. Many traits 
are controlled by several loci, where each 
can contribute to the variation in the trait 
and hence are called quantitative trait loci 
(QTL). These molecular markers are used 
to identify loci or chromosomal regions 
that affect single gene traits and also QTLs. 
The idea behind this is to use these genetic 
markers rather than the phenotypes in a 
process called marker-assisted selection, or 
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advances in animal reproductive tech-
nology promise new possibilities, but many 
ethical challenges have emerged with the de-
velopment of the fourth generation technol-
ogies, including therapeutic and reproduc-
tive cloning, stem cell biology, cell and gene 
therapy and transgenesis. The religious, 
ethical and political turmoil caused by these 
reproductive technologies is important and 
absolutely necessary, and should serve as an 
alert for responsibility and accountability to 
professionals in the field and related areas. 
Since reproductive technologies can benefit 
mankind, any emerging new development 
should be extensively and fully tested in 
laboratory and domestic animals before any 
attempts are made to make them available 
for humans. Consequently, more restraint 
and thoughtful consideration of each tech-
nological advance should be made before its 
application to human medicine (31). 
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fluence livestock industry in the near future. 
With the development of the forth genera-
tion of arT, the potential of farm animals 
for improving human health is growing and 
many areas remain to be explored and, when 
associated with modern molecular tools, 
will further advance progress in animal 
breeding and genetics (28). in this regard, 
the use of molecular markers will favor an 
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